SecBot SecBot
PRESS-RELEASE ·Filed May 5, 2026

SCLX

Scilex Holding Company
BULLISH
Impact 8/10
Horizonmonths Processed6mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ▲ Bullish

The deal positions Scilex to benefit from a newly listed entity valued at $1B. Traders should monitor closing conditions and regulatory approvals; successful completion could lead to a significant re-rating of SCLX. Watch for any financing or dilution details as the transaction progresses.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$6.68
T+0 close · May 5, 2026 · via day close
Latest settled
−1.22%
T+60 · $6.60
Vs SPY
−3.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $6.68entry
  2. T+1 · 7mo ago −11.46%α −12.85% · $5.92
  3. T+5 · 6mo ago −36.53%α −38.52% · $4.24
  4. T+20 · 6mo ago −33.18%α −37.39% · $4.46
  5. T+60 · 4mo ago −1.22%α −3.96% · $6.60
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Scilex's indirect subsidiary, ACEA Therapeutics, has agreed to sell ACEA Pharma to Phoenix Asia Holdings in exchange for 100M newly-issued Phoenix shares valued at $1B. Upon closing, Scilex's subsidiary will own ~82% of the combined company, which will be renamed ACEA Pharma and list on Nasdaq. This transformative deal could significantly increase the value of Scilex's assets, but is subject to regulatory and stock exchange approvals.

Key Financial Metrics

Deal Value
$1.0B

Key Facts

  • Deal value: $1,000,000,000 (100,000,000 shares at $10.00/share)
  • ACEA Thera (Scilex subsidiary) to receive 100M shares of Phoenix, representing ~82% of the combined entity
  • Phoenix to be renamed ACEA Pharma, Inc. and list on Nasdaq
  • Expected closing by end of Q2 2026, subject to regulatory and Nasdaq approval
  • SCLX market cap is ~$95M, making this a potentially transformative event

Financial Impact

$1 billion acquisition of ACEA Pharma by Phoenix, with Scilex's subsidiary receiving 82% ownership stake

acquisitionownership stake

Risk Factors

  • Failure to obtain regulatory or Nasdaq approval
  • Delays or termination of the acquisition agreement
  • Potential dilution or unfavorable terms for Scilex shareholders
  • Integration and execution risks for the combined company

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3288095

Track record

11 reports on SCLX

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +34.62% at T+60 after the Jun 29, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Jul 22, 202616w ago 8-K Mixed 5/10 Entry $7.39 to $2.82 Now $1.25 −83.09% ▼ −61.84% −66.39% vs SPY
  2. Jul 6, 202619w ago 8-K Mixed 6/10 Entry $8.07 to $4.41 Now $1.25 −84.51% ▼ −45.35% −47.07% vs SPY
  3. Jun 29, 202620w ago 8-K Bearish 7/10 Entry $7.80 to $5.10 Now $1.25 +83.97% ▲ +34.62% +37.43% vs SPY
  4. Jun 12, 202622w ago Press Release Neutral 2/10 Entry $8.50 to $8.35 Now $1.25 −85.29% ▼ −1.75% −4.53% vs SPY
  5. Jun 12, 202622w ago EFFECT Bearish 6/10 Entry $8.50 to $8.35 Now $1.25 +85.29% ▲ +1.75% +4.53% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $8.70 to $8.62 Now $1.25 −85.63% ▼ −0.87% −4.69% vs SPY
  7. Jun 4, 202623w ago Press Release Neutral 4/10 Entry $4.72 to $5.43 Now $1.25 −73.52% ▲ +15.05% +13.17% vs SPY
  8. May 5, 202627w ago Press Release Bullish 8/10 Viewing Entry $6.68 to $6.60 Now $1.25 −81.29% ▼ −1.22% −3.96% vs SPY
  9. May 4, 202628w ago Press Release Neutral 4/10 Entry $6.94 to $6.56 Now $1.25 −82.00% ▼ −5.51% −7.37% vs SPY
  10. Apr 17, 202630w ago Insider Cluster Mixed 6/10 Entry $4.30 to $8.76 Now $1.25 −70.91% ▲ +103.89% +97.75% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026